Jim Cramer Holds Back on GoodRx (GDRX)

We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other stocks that Jim Cramer discusses.

Noting that Cramer has not said anything about GoodRx Holdings, Inc. (NASDAQ:GDRX) in a long time, a caller asked about the company. In response, Cramer said:

“Sometimes, like my Nana Mary said, if you don’t have anything good to say about someone, don’t say it at all.”

Jim Cramer Holds Back on GoodRx (GDRX)

A pharmacist assisting elderly customers with their GoodRX codes at a local pharmacy.

GoodRx (NASDAQ:GDRX) provides tools that help people find lower prices on prescription drugs, along with subscriptions, telehealth services, and healthcare solutions for both humans and pets. In 2022, when a caller asked about the company during a lightning round, Cramer said, “These are all no-go. They’re in a no-fly zone. You’ve just got to look at it like that.” For context, GDRX stock has gone down more than 82% since the comment was aired.

Overall, GDRX ranks 11th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of GDRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GDRX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.